| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_46b65993c75114bf9f710027d465c931
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2d3ce107406b896b38f01fef573742a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_942e9991d33292a8615f2d546ed430b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2135217604c14b59fdd4c4353ee4163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed28726de9f916f355f8adc331e736b8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-117 |
| filingDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16e8177075bc95e4d25704361e7b3bb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84b9205b7329b823e6c9275af3c1c251
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e3d4eae6a8e7deb453404e445a2899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bceb38cde424195c3daa8ba073db66e9 |
| publicationDate |
2019-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10383887-B2 |
| titleOfInvention |
Preventing and treating amyloid-beta deposition by stimulation of innate immunity |
| abstract |
The present invention is directed to a method of preventing or reducing amyloid deposition in a subject. This method involves selecting a subject with amyloid deposits and stimulating the innate immune system of the selected subject under conditions effective to reduce the amyloid deposits. Also disclosed is a method of preventing or treating cerebral amyloidosis and Alzheimer's Disease in a subject by administering to the selected subject an agent that stimulates the innate immune system. In addition, a composition useful for the stimulation of the innate immune system of a subject exhibiting symptoms associated with amyloid deposition is disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10960019-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874725-B2 |
| priorityDate |
2008-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |